Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxil in CDOP-R for Elderly or Cardiac-Compromised DLBCL
NCT00333008Phase 2Unknown
- Sponsor
- Lapidus Cancer Institute
- Start
- May 2006
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, open-label trial of pegylated liposomal doxorubicin in diffuse large B-cell lymphoma (DLBCL), sponsored by Lapidus Cancer Institute. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00333008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333008.